Ad is loading...
MENU
HART
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

HART stock forecast, quote, news & analysis

Category: @Health
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOGL), Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), AstraZeneca PLC (NASDAQ:AZN), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Nike (NYSE:NKE), Elevance Health (NYSE:ELV).

Industry description

The investment seeks investment results that correspond generally to the price and yield performance of its underlying index, the NYLI Candriam Healthy Hearts Index. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the index, which was developed by IndexIQ LLC with Candriam acting as index consultant to IndexIQ. The index includes securities of large-, mid- and small-capitalization companies that trade in the U.S. and foreign markets, including emerging markets other than China, Egypt, India, Kuwait, Pakistan, Qatar, Saudi Arabia and United Arab Emirates. It is non-diversified.

Market Cap

The average market capitalization across the NYLI Healthy Hearts ETF ETF is 167.34B. The market cap for tickers in the group ranges from 3.51M to 2.62T. AAPL holds the highest valuation in this group at 2.62T. The lowest valued company is NOVN at 3.51M.

High and low price notable news

The average weekly price growth across all stocks in the NYLI Healthy Hearts ETF ETF was 1%. For the same ETF, the average monthly price growth was -3%, and the average quarterly price growth was 3%. PTON experienced the highest price growth at 23%, while THC experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the NYLI Healthy Hearts ETF ETF was -36%. For the same stocks of the ETF, the average monthly volume growth was 1% and the average quarterly volume growth was 13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 60
Price Growth Rating: 45
SMR Rating: 57
Profit Risk Rating: 49
Seasonality Score: 34 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
800 Westchester Avenue,Suite N611Rye Brook
Phone
1-888-934-0777
Web
www.indexiq.com